Paul J Mellett, Enanta Pharmaceuticals Inc's Treasurer and CFO, just received 30,000 options from the company. The strike price of the options received was $31.42, and these expire on November 20, 2025. Mellett now owns at least 30,000 options on the company.
Some additional info was provided as follows:
Such option will become exercisable (subject to the optionholder's continued employment) quarterly in substantially equal installments (any fractional shares to be cumulated and to become exercisable at the end of the earliest succeeding quarterly period in which a whole share equivalent is accumulated) over four years from the date of grant (November 20, 2015).
The above information was disclosed in a filing to the SEC. To see thi s filing in its entirety, click here.
To receive a free e-mail notification whenever Enanta Pharmaceuticals Inc makes a similar move, sign up!
Other recent filings from the company include the following:
Enanta Pharmaceuticals Inc's President and CEO just disposed of 25,000 shares - May 18, 2018
Enanta Pharmaceuticals Inc's Sr. VP & Chief Medical Officer just disposed of 1,200 shares - May 18, 2018
Mark C. Wehrly just provided an update on share ownership of Enanta Pharmaceuticals Inc - May 10, 2018
Enanta Pharmaceuticals Reports Financial Results For Its Fiscal Second Quarter Ended - May 8, 2018